Specialist Updates 
Rheumatology

COVID-19: Alarm over clamour for hydroxychloroquine

There's rising interest in the drug to fight coronavirus, but this could threaten supply for current indications, warn rheumatologists
Lydia Hales
4
27 March 2020
Save

The TGA has restricted initiation of hydroxychloroquine to specialists in the wake of concern about a run on the drug for off-label use as prophylaxis against COVID-19.

The Australian Rheumatology Association (ARA) and Pharmaceutical Society of Australia have each raised concerns about the potential for supply shortages of the drug, which is in several trials worldwide as a potential therapy or preventive for coronavirus.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .